-

Best's Commentary: Outcome of Ogden Rate Review Will Be a Relief for UK Insurers

LONDON--(BUSINESS WIRE)--AM Best believes newly announced changes to the U.K. personal injury discount rate (PIDR), otherwise known as the Ogden Discount Rate, should be positive for the country’s non-life insurers.

In its new Best’s Commentary, “Outcome of the Ogden Rate Review Will Be a Relief for UK Insurers”, AM Best notes the new personal injury discount rate of 0.5%, announced in early December 2024, is within the expected range anticipated by U.K. insurers.

The new discount rate should ease the pressure on U.K. non-life underwriting results in what is an extremely competitive and price sensitive market. At present, it is not expected to have an impact on credit ratings.

To access a complimentary copy of this market segment report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=349465.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Ben Diaz-Clegg
Associate Director, Analytics
+44 20 7397 0293
ben.diaz-clegg@ambest.com

Ghislain Le Cam
Senior Director, Analytics
+44 20 7397 0268
ghislain.lecam@ambest.com

Richard Banks
Director, Industry Research – EMEA
+44 20 7397 0322
richard.banks@ambest.com

Edem Kuenyehia
Director, Market Development & Communications
+44 20 7397 0280
edem.kuenyehia@ambest.com

AM Best


Release Versions
Hashtags

Contacts

Ben Diaz-Clegg
Associate Director, Analytics
+44 20 7397 0293
ben.diaz-clegg@ambest.com

Ghislain Le Cam
Senior Director, Analytics
+44 20 7397 0268
ghislain.lecam@ambest.com

Richard Banks
Director, Industry Research – EMEA
+44 20 7397 0322
richard.banks@ambest.com

Edem Kuenyehia
Director, Market Development & Communications
+44 20 7397 0280
edem.kuenyehia@ambest.com

Social Media Profiles
More News From AM Best

AM Best Affirms Credit Ratings of Nova Casiopea Re S.A.

AMSTERDAM--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Nova Casiopea Re S.A. (NCRe) (Luxembourg). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect NCRe’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management. NCRe is a single-parent captive of...

AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of “bbb” (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of...

AM Best to Host Briefing on Challenges, Opportunities for Health Insurers in Medicare Advantage Segment

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will host a briefing with a panel of health insurance industry experts to discuss their outlook on the Medicare Advantage business segment of the U.S. health insurance industry, scheduled for Thursday, Jan. 15, 2026, at 2:00 p.m. EST. AM Best has a negative outlook on the U.S. health insurance industry and the Medicare Advantage and Medicaid Managed Care segments, owning to a number of adverse factors. Medicare Advantage plans have been experiencing press...
Back to Newsroom